Advanced Biomed Inc. Regains Nasdaq Listing Compliance

Advanced Biomed Inc. received a notice on July 18, 2025, from Nasdaq indicating its common stock had fallen below the $1.00 minimum bid price requirement. The company was granted 180 days to comply, but failed to do so by January 14, 2026. Subsequently, Nasdaq scheduled the company's securities for delisting. Advanced Biomed Inc. appealed this decision on January 21, 2026, and presented a compliance plan, including a reverse stock split approved by stockholders on January 12, 2026. On March 12, 2026, the company received a decision from the Nasdaq Listing Qualifications Hearings Department confirming it had regained compliance with the minimum bid price requirement following a reverse stock split completed on February 20, 2026. The company's common stock will remain listed on the Nasdaq Capital Market, subject to a one-year monitoring period.